Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The distribution of the following variables showed significant differences between quartiles: age, race, gender, income-to-poverty ratio, education, waist circumference, BMI, moderate activity, smoking habits, hyperuricemia, hypertension and diabetes, HDL-C, serum uric acid, serum creatinine, total cholesterol, HbA1c, triglycerides and Vitamin D (all P < 0.05).

Source: Baseline characteristics. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Association between cardiometabolic index and cardiovascular disease: evidence From the NHANES 2007 to 2018

Study design awaiting verification · Frontiers in Cardiovascular Medicine · 2025

Original publication title

Association between cardiometabolic index and cardiovascular disease: evidence From the NHANES 2007 to 2018

Feiyu Chen; Yongquan Niu; Runzhe Wu; Haodong Jiang; Jia Zhu; Congying Wang; Xiaojun Xia; Yunpeng Jin

© 2025 Chen, Niu, Wu, Jiang, Zhu, Wang, Xia and Jin.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Among US adults, having higher CMI levels is substantially associated with higher odds of CVD prevalence. This finding suggests that regular monitoring of CMI levels could enable physicians to initiate early interventions, potentially slowing the progression of CVD. However, in order to corroborate our findings, further prospective investigations are still required.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Although the cardiometabolic index (CMI) has gained recognition as a new tool for evaluating metabolic health, the relationship between CMI and cardiovascular disease (CVD) remains unclear. This research sought to explore the potential association between CMI and CVD.

Source: Background

Abstract: What methods does the paper describe?

Participants from the 2007 to 2018 National Health and Nutrition Examination Survey (NHANES) were selected. Multivariable logistic regression analyses and smooth curve fitting were utilized to investigate this relationship, along with subgroup evaluations and interaction analyses.

Source: Methods

Abstract: Results

This study included 12,837 subjects and the prevalence of CVD was 11.83%. After full adjustment, participants presenting with an increase of one unit in Ln-transformed CMI associated a 15% higher odds of CVD prevalence (OR = 1.15, 95% CI: 1.05 to 1.26). In the fully adjusted model, individuals falling into the highest CMI quartile (Quartile 4) demonstrated substantially 35% higher odds than those in the lowest CMI quartile (Quartile 1) (OR = 1.35, 95% CI: 1.11 to 1.66). In addition, there was no nonlinear relationship between CMI and CVD in our selected sample.

This positive association was not greatly influenced by any of the stratifications.

Source: Results

Abstract: Conclusions

Among US adults, having higher CMI levels is substantially associated with higher odds of CVD prevalence. This finding suggests that regular monitoring of CMI levels could enable physicians to initiate early interventions, potentially slowing the progression of CVD. However, in order to corroborate our findings, further prospective investigations are still required.

Source: Conclusions
Authors’ abstract

Background

Although the cardiometabolic index (CMI) has gained recognition as a new tool for evaluating metabolic health, the relationship between CMI and cardiovascular disease (CVD) remains unclear. This research sought to explore the potential association between CMI and CVD.

Methods

Participants from the 2007 to 2018 National Health and Nutrition Examination Survey (NHANES) were selected. Multivariable logistic regression analyses and smooth curve fitting were utilized to investigate this relationship, along with subgroup evaluations and interaction analyses.

Results

This study included 12,837 subjects and the prevalence of CVD was 11.83%. After full adjustment, participants presenting with an increase of one unit in Ln-transformed CMI associated a 15% higher odds of CVD prevalence (OR = 1.15, 95% CI: 1.05 to 1.26). In the fully adjusted model, individuals falling into the highest CMI quartile (Quartile 4) demonstrated substantially 35% higher odds than those in the lowest CMI quartile (Quartile 1) (OR = 1.35, 95% CI: 1.11 to 1.66). In addition, there was no nonlinear relationship between CMI and CVD in our selected sample.

This positive association was not greatly influenced by any of the stratifications.

Conclusions

Among US adults, having higher CMI levels is substantially associated with higher odds of CVD prevalence. This finding suggests that regular monitoring of CMI levels could enable physicians to initiate early interventions, potentially slowing the progression of CVD. However, in order to corroborate our findings, further prospective investigations are still required.

Publication and source details

Original title: Association between cardiometabolic index and cardiovascular disease: evidence From the NHANES 2007 to 2018

Feiyu Chen; Yongquan Niu; Runzhe Wu; Haodong Jiang; Jia Zhu; Congying Wang; Xiaojun Xia; Yunpeng Jin

Frontiers in Cardiovascular Medicine · 2025

Edited by: Chiara Macchi, University of Milan, Italy

Reviewed by: Nicolas Padilla-Raygoza, Institute of Public Health of the State of Guanajuato (ISAPEG), Mexico

Mustafa Şahin, Ankara University, Türkiye

* Correspondence: Yunpeng Jin 8013013@zju.edu.cn
© 2025 Chen, Niu, Wu, Jiang, Zhu, Wang, Xia and Jin.2025Chen, Niu, Wu, Jiang, Zhu, Wang, Xia and Jinhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declare that no financial support was received for the research and/or publication of this article.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:13:51.112758+00:00

DOI: 10.3389/fcvm.2025.1516591 · PMC12104185